- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT00758719
Evaluate Effectiveness of the Biomet Lumbar Spinal Fusion System
February 20, 2020 updated by: Zimmer Biomet
A Prospective Multicenter Lumbar Spine Fusion Study to Evaluate the Effectiveness of the Biomet Lumbar Spinal Fusion System
The purpose of this study is to evaluate the effectiveness of the Biomet Lumbar Spinal Fusion System in patients undergoing lumbar fusion surgery.
Study Overview
Status
Completed
Conditions
Detailed Description
All subjects enrolled in this study will receive the The Biomet Osteobiologic Treatment System which is comprised of the SpF® Spine Fusion Stimulator and any or all of the following can be utilized in the study: any Pedicle Screw System, autograft and an Interbody Spacer
Study Type
Observational
Enrollment (Actual)
53
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Indiana
-
Terre Haute, Indiana, United States, 47807
- Union Hospital Neurosurgical
-
-
Michigan
-
Flint, Michigan, United States, 48507
- Family Orthopedic Associates
-
-
Ohio
-
Columbus, Ohio, United States, 43212
- Orthopedics and Neurological Consultants, Inc
-
-
Wisconsin
-
Waukesha, Wisconsin, United States, 53188
- Neurological Associates of Waukesha
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years to 75 years (Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Sampling Method
Non-Probability Sample
Study Population
This study is open to all patients with one or two level Degenerative Disease who are between the ages of 18 and 75.
Description
Inclusion Criteria:
- The subject must, in the investigator's opinion, be psychosocially, mentally, and physically able to fully comply with this protocol including the required follow-up visits, the filling out of required forms, and have the ability to understand and give written informed consent.
- The subject must be diagnosed with degenerative disc disease at up to 2 levels from L2-S1 inclusive and undergoing up to 2 level posterior lumbar spinal fusion surgery with or without anterior column fusion.
- Subjects must be between 18 and 75 years of age.
- The patient must be skeletally mature (epiphyses closed).
Exclusion Criteria:
- Subject is pregnant, lactating or interested in becoming pregnant during the duration of the study.
- Any active litigation.
- Subject is currently involved in another investigational study.
- Subject has a history (present or past) of substance abuse (recreational drugs, prescription drugs or alcohol) that in the investigator's opinion may interfere with protocol assessments and/or with the subject's ability to complete the protocol required follow-up.
- Subject is incarcerated.
- More than 2 prior spine surgeries/revision surgeries or any previous spinal fusions at levels being currently treated.
- Traumatic instability.
- Any parathyroid or metabolic bone disease.
- Any active malignancy.
- Osteopenia/Osteoporosis - All subjects will be screened for osteoporosis using SCORE (Simple Calculated Osteoporosis Risk Estimation) with a threshold value of 6. All subjects with a SCORE value greater than 6 will be referred for Dual-energy X-ray absorptiometry (DEXA) Scan. Subjects with a T-Score of £-1-2.5 will be excluded.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
---|---|
Radiographic Fusion
Time Frame: 12 Month
|
12 Month
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Visual Analog Scale (VAS) change from baseline
Time Frame: 24 Months
|
Mean VAS % change from baseline
|
24 Months
|
Oswestry Disability Index change from baseline
Time Frame: 24 Month
|
Oswestry Disability Index % change from baseline
|
24 Month
|
Neurologic Assessment, Maintenance or improvement from baseline
Time Frame: 12 Month
|
12 Month
|
|
Short Form Health Survey (SF-36) % change from baseline
Time Frame: 24 Month
|
24 Month
|
|
Time to return to work
Time Frame: 24 month
|
24 month
|
|
Time to return to normal activity
Time Frame: 24 month
|
24 month
|
|
Narcotic Use
Time Frame: 24 month
|
pre and post-operatively
|
24 month
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Study Director: Joel Batts, Biomet Spine
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
September 1, 2008
Primary Completion (Actual)
August 1, 2012
Study Completion (Actual)
August 1, 2012
Study Registration Dates
First Submitted
September 9, 2008
First Submitted That Met QC Criteria
September 23, 2008
First Posted (Estimate)
September 25, 2008
Study Record Updates
Last Update Posted (Actual)
February 24, 2020
Last Update Submitted That Met QC Criteria
February 20, 2020
Last Verified
February 1, 2020
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- CS-045
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
UNDECIDED
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Degenerative Disc Disease
-
Assistance Publique - Hôpitaux de ParisTerminatedCervical Degenerative Disc Disease | Kyphosis | Lumbar Degenerative Disc DiseaseFrance
-
Synergy Spine SolutionsMCRARecruitingCervical Degenerative Disc DiseaseUnited States
-
Orthofix Inc.TerminatedCervical Degenerative Disc DiseaseUnited States
-
Assiut UniversityNot yet recruiting
-
Spine BioPharma, IncMCRARecruitingLumbar Degenerative Disc DiseaseUnited States
-
AxioMed Spine CorporationUnknownDegenerative Disc Disease (DDD)United States, Germany
-
Synthes USA HQ, Inc.CompletedLumbar Degenerative Disc Disease
-
DePuy InternationalTerminatedCervical Degenerative Disc DiseaseAustralia, Germany, Italy, Malaysia, Netherlands, Spain, United Kingdom
-
Yuhan CorporationCompletedDisc Degenerative DiseaseKorea, Republic of
-
Synergy Spine SolutionsMCRAActive, not recruitingCervical Degenerative Disc DiseaseUnited States